(Circulation. 1995;91:2898-2903.)
© 1995 American Heart Association, Inc.
Articles |
In Vitro Responses of Human Peripheral Small Arteries in Hypercholesterolemia and Effects of Therapy
Presented at the 66th Annual Scientific Sessions of the American Heart Association, Atlanta, Ga, November 10, 1993.
From the Department of Medicine, University of Manchester, England.
Correspondence to Prof A.M. Heagerty, MD, FRCP, Department of Medicine, Withington Hospital, Nell Lane, West Didsbury, Manchester, UK, M20 8LR.
Background Studies in both animals and humans with raised lipid levels have demonstrated abnormalities in vascular function usually manifested by an impairment in endothelium-dependent vasorelaxation. This is believed to be an early event in atheroma formation. There are few data on the effects on vascular function in humans of lowering serum lipids. We conducted a study to investigate the effects of cholesterol reduction on the in vitro function of human peripheral small arteries in middle-aged patients with hypercholesterolemia.
Methods and Results Subcutaneous gluteal fat biopsies were taken from 18 hypercholesterolemic (HC) patients (mean±SEM serum total cholesterol, 9.7±0.57 mmol/L) and 16 age- and sex-matched control subjects (mean cholesterol, 4.69±0.18 mmol/L). Subcutaneous small arteries (internal diameter, <330 µm) were dissected and mounted on a wire myograph for isometric tension measurements. The HC patients showed impaired relaxation to acetylcholine (10-9 to 10-6 mol/L) after preconstriction with the thromboxane A2 analogue U46619 (10-6 mol/L, mean maximum relaxation, 42.9±5.4%) compared with control subjects (85.7±4.0%, P<.00001). Incubation with the nitric oxide substrate L-arginine (3 mmol/L) improved the endothelium-dependent vasorelaxation response to acetylcholine (70.9±6.0%, P<.01) in patients but not in control subjects. Also, there was a smaller but significant difference in responses to the endothelium-independent agent sodium nitroprusside (10-9 to 10-6 mol/L) between the HC group (mean maximum relaxation, 76.9±6.0%) and the control subjects (89.7±6%; P<.01). A total of 10 patients had a second gluteal skin biopsy and repeat functional studies after successful cholesterol-lowering therapy after a mean period of 9.9±4.7 months. A significant reduction in total and LDL cholesterol was achieved (5.29±0.2 and 3.23±0.21 mmol/L, respectively; P<.001). This restored vasorelaxation to control values in response to both acetylcholine (mean maximum relaxation, 83.3±3.8%; P<.0001) and sodium nitroprusside (87.9±4.8%, P<.01). Although both groups were normotensive, there were significantly higher blood pressures in the HC group compared with control subjects (139±4.1 versus 123±3.0 mm Hg systolic, P<.01; 84±1.3 versus 75±2.2 mm Hg diastolic, P<.01). There was no difference in initial blood pressures between the entire group of 18 and the 10 patients who had repeat biopsies. The blood pressures fell to control values after cholesterol reduction (129.33±4.93 mm Hg systolic and 72.33±2.93 diastolic mm Hg, P<.02 relative to pretreatment values).
Conclusions These results demonstrate abnormalities of both endothelium-dependent and -independent relaxation in human peripheral small arteries that are normalized with effective lipid lowering. The changes in blood pressure may have been secondary to the improvement in vascular function.
Key Words: hypercholesterolemia • endothelium • blood pressure • arteries
This article has been cited by other articles:
 |
|
 |
|
  U. Sen, N. Tyagi, M. Kumar, K. S. Moshal, W. E. Rodriguez, and S. C. Tyagi Cystathionine- -synthase gene transfer and 3-deazaadenosine ameliorate inflammatory response in endothelial cells Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1779 - C1787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A.J. van der Linde, E. J.G. Sijbrands, F. Boomsma, and A. H. van den Meiracker Effect of Low-Density Lipoprotein Cholesterol on Angiotensin II Sensitivity: A Randomized Trial With Fluvastatin Hypertension, June 1, 2006; 47(6): 1125 - 1130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Malik, I. J. Schofield, A. Izzard, C. Austin, G. Bermann, and A. M. Heagerty Effects of Angiotensin Type-1 Receptor Antagonism on Small Artery Function in Patients With Type 2 Diabetes Mellitus Hypertension, February 1, 2005; 45(2): 264 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M.R. Gill, A. Al-Mamari, W. R. Ferrell, S. J. Cleland, C. J. Packard, N. Sattar, J. R. Petrie, and M. J. Caslake Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2375 - 2382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bahring, A. Rauch, O. Toka, C. Schroeder, C. Hesse, H. Siedler, G. Fesus, W. E. Haefeli, A. Busjahn, A. Aydin, et al. Autosomal-Dominant Hypertension With Type E Brachydactyly Is Caused by Rearrangement on the Short Arm of Chromosome 12 Hypertension, February 1, 2004; 43(2): 471 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Holemans, L. Aerts, and F. A. Van Assche Fetal Growth Restriction and Consequences for the Offspring in Animal Models Reproductive Sciences, October 1, 2003; 10(7): 392 - 399. [Abstract] [PDF]
|
|
|
|
 |
|
 I. Schofield, R. Malik, A. Izzard, C. Austin, and A. Heagerty Vascular Structural and Functional Changes in Type 2 Diabetes Mellitus: Evidence for the Roles of Abnormal Myogenic Responsiveness and Dyslipidemia Circulation, December 10, 2002; 106(24): 3037 - 3043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A Van Assche, K. Holemans, and L. Aerts Long-term consequences for offspring of diabetes during pregnancy Br. Med. Bull., November 1, 2001; 60(1): 173 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Koh Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability Cardiovasc Res, September 1, 2000; 47(4): 648 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Schiffrin, J. B. Park, H. D. Intengan, and R. M. Touyz Correction of Arterial Structure and Endothelial Dysfunction in Human Essential Hypertension by the Angiotensin Receptor Antagonist Losartan Circulation, April 11, 2000; 101(14): 1653 - 1659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Peterson, M. Courtois, L. F. Peterson, M. R. Peterson, V. G. Dávila-Román, R. J. Spina, and B. Barzilai Estrogen Increases Hyperemic Microvascular Blood Flow Velocity in Postmenopausal Women J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2000; 55(3): 174M - 179. [Abstract] [Full Text]
|
|
|
|
|
|
S. E. Brett, J. M. Ritter, and P. J. Chowienczyk Diastolic Blood Pressure Changes During Exercise Positively Correlate With Serum Cholesterol and Insulin Resistance Circulation, February 15, 2000; 101(6): 611 - 615. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Khan, S. J Litchfield, P. A Stonebridge, and J. J. Belch Lipid-lowering and skin vascular responses in patients with hypercholesterolaemia and peripheral arterial obstructive disease Vascular Medicine, November 1, 1999; 4(4): 233 - 238. [Abstract] [PDF]
|
|
|
|
|
|
S. J Duffy, G. New, R. W Harper, and I. T Meredith Metabolic vasodilation in the human forearm is preserved in hypercholesterolemia despite impairment of endothelium-dependent and independent vasodilation Cardiovasc Res, August 15, 1999; 43(3): 721 - 730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cooper and A. M. Heagerty Endothelial dysfunction in human intramyocardial small arteries in atherosclerosis and hypercholesterolemia Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1482 - H1488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. FARACI and D. D. HEISTAD Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels Physiol Rev, January 1, 1998; 78(1): 53 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. Goode, S. Garcia, and A. M. Heagerty Dietary Supplementation With Marine Fish Oil Improves In Vitro Small Artery Endothelial Function in Hypercholesterolemic Patients : A Double-Blind Placebo-Controlled Study Circulation, November 4, 1997; 96(9): 2802 - 2807. [Abstract] [Full Text]
|
|
|
|
|
|
V. Guetta and R. O. Cannon III Cardiovascular Effects of Estrogen and Lipid-Lowering Therapies in Postmenopausal Women Circulation, May 15, 1996; 93(10): 1928 - 1937. [Full Text]
|
|